Possible therapeutic role of vitamin D3 in aggressive fibromatosis

Japanese Journal of Clinical Oncology

Volumn 34, Issue 8, 2004, Pages 472-475

  Ferah, Yildiz ^a   Ayse, Kars ^a   Mustafa, Cengiz ^a   Ugur, Selek ^a   Murat, Gurkaynak ^a   Lale, Atahan I ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Aggressive fibromatosis; Vitamin D3

Indexed keywords

CALCITRIOL; CYCLOPHOSPHAMIDE; DACTINOMYCIN; TAMOXIFEN; TOREMIFENE; VINCRISTINE; COLECALCIFEROL;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CASE REPORT; DISEASE COURSE; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG RESPONSE; FEMALE; FIBROMATOSIS; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; SHOULDER; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; TUMOR VOLUME; RADIATION DOSE;

ADULT; CHOLECALCIFEROL; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; MAGNETIC RESONANCE IMAGING; RADIOTHERAPY DOSAGE; SHOULDER;

EID: 7944230121     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyh075     Document Type: Article

References (33)

1. Shields CJ, Winter WO, Kirwan WO, Redmond HP. Desmoid tumors. Eur J Surg Oncol 2001;27:701-6.
2. Nuyttens JJ, Rust FR, Thomas CR, Turrisi AT. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors. A comparative review of 22 articles. Cancer 2000;88:1517-23.
3. Janinis J, Patriki M, Vini L, et al. The pharmacological treatment of aggressive fibromatosis: A systematic review. Ann Oncol 2003; 14:181-90.
4. Casado M, Martin M, Munoz A, Bernal J. Vitamin D3 inhibits proliferation and increases c-myc expression in fibroblasts from psoriatic patients. J Endocrinol Invest 1998;21:520-5.
5. Abe E, Miyaura C, Sakagami H, et al. Differentiation of mouse myeloid leukemia cells induced by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1981;76:4990-4.
6. Akther J, Lu I, Finlay M, et al. 1α,25-dihydroxy vitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HEPG2. Aust NZ J Surg 2001;71:414-7.
7. Akther J, Goerdel M, Morris DL. A vitamin D3 analogue (EB1089) inhibits in vitro cellular proliferation of human colon cancer cells. Br J Surg 1996;83:229-30.
8. James SY, Mackay AG, Colston KW. Effects of 1,25-dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells. Steroid Biochem Mol Biol 1996;58:395-401.
9. Polar MK, Gennings C, Park M, et al. Effect of the vitamin D3 analog ILX 23-7553 on apoptosis and sensitivity to fractionated radiation in breast tumor cells and normal human fibroblasts. Cancer Chemother Pharmacol 2003;51:415-21.
10. Hyodo H, Kimura A, Nakata Y, et al. 1-alpha-Hydroxyvitamin D3 in the treatment of primary myelofibrosis: In vitro effect of vitamin D3 metabolites on the bone marrow fibroblasts. Int J Hematol 1993;57:131-7.
11. Azzarelli A, Gronchi A, Bertulli R, et al. Low dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 2001;92:1259-64.
12. Ocuno SH, Edmonson JH. Combination chemotherapy for desmoid tumors. Cancer 2003;97:1134-5.
13. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer 1993;72:3244-7.
14. Jadrijevic D, Mardones E, Lipschutz A. Antifibromatogenic potency of 9-fluoro derivates of progesterone. Nature 1956;178:139-47.
15. Bruzzone S, Elqueta H, Lipschultz A. Oestrogen-induced fibroids of the thoracic serosa. Br J Cancer 1948;2:268-74.
16. Tonelli F, Ficari F, Valanzxano R, Brandi ML. Treatment of desmoids and mesenteric fibromatosis in familial adenomatosis poliposis with raloxifene. Tumori 2003;89:391-6.
17. Brooks MD, Ebbs SR, Colletta AA, et al. Desmoid tumors treated with triphenylenes. Eur J Cancer 1992;28A:1014-8.
18. Lanari A. Effect of progesterone on desmoid tumors (aggressive fibromatosis). N Engl J Med 1983;309:1523-6.
19. Waddell WR, Kirsch WM. Testolactone, sulindac, warfarin and vitamin K1 for unresectable desmoid tumors. Am J Surg 1991;161:416-21.
20. Waddell WR, Gerner RE. Indomethacin and ascorbate inhibit desmoid tumors. J Surg Oncol 1980;15:85-90.
21. Klein WA, Miller HH, Anderson M, et al. The use of indomethacin, sulindac and tamoxifen for the treatment of desmoid tumors associated with familial poliposis. Cancer 1987;60:2863-8.
22. Tsukada K, Church JM, Jagelman DJ, et al. Noncytotoxic therapy for intra-abdominal desmoid tumor in patients with familial adenomatosis poliposis. Dis Colon Rectum 1992;35:29-33.
23. Hansmann A, Adolp C, Vogel T, et al. High dose tamoxifen and sulindac as first line treatment for desmoid tumors. Cancer 2004; 100:612-20.
24. Swamy N, Persons KS, Chen TC, Ray R. 1alpha,25-Dihydroxyvitamin D3-3beta-(2)-bromoacetate, an affinity labeling derivative of 1alpha, 25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells. J Cell Biochem 2003;89:909-16.
25. Evans SR, Houghton AM, Schumaker L, et al. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines. J Surg Res 1996;15:61:127-33.
26. Wu G, Fan RS, Li W, et al. Modulation of cell cycle control by Vitamin D3 and its analogue EB 1089 in human breast cancer cell lines. Oncogene 1997;15(13):1555-63.
27. Koli K, Keski-Oja J. 1,25-dihydroxyvitamin D3 enhances the expression of transforming growth factor β1 and latent form binding protein in breast carcinoma cells. Cancer Res 1995;55:1540-6.
28. Hirri HM, Gren RJ. Myelodysplasia and bone marrow fibrosis treated with calcitriol and venesection. Leuk Lymphoma 2002;43:1489-91.
29. McCarthy DM, Hibbin JA, Goldman JM. A role for 1,25-dihydroxyvitamin D3 in control of bone marrow collagen deposition. Lancet 1984; 1:78-80.
30. McCollough WM, Parsons JT, van der Griend, et al. Radiation therapy for aggressive fibromatosis: The experience at the University of Florida. J Bone Joint Surg 1991;73:717-25.
31. Acker JC, Bossen EH, Halperin EC. The management of desmoid tumors. Int J Radiat Oncol Biol Phys 1993;26:851-8.
32. Sundaram S, Chaudhry M, Reardon D, et al. EB 1089 enhances the antiproliferative and apoptotic effects of adriamycin in MCF-7 breast tumor cells. Breast Cancer Res Treat 2000;63:1-10.
33. Sundaram S, Sea A, Feldman S, et al. The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin Cancer Res 2003;9:2350-6.